(Q51745474)

11 April 2018

editorial

0 references

title

Hepatitis B surface antigen quantification as a current-day paradox: obtaining the gold in the face of diminishing returns. (English)

1 reference

11 April 2018

author name string

Robert P Perrillo

series ordinal

1

1 reference

11 April 2018

language of work or name

English

0 references

publication date

1 April 2009

1 reference

11 April 2018

published in

Hepatology

1 reference

11 April 2018

volume

49

1 reference

11 April 2018

issue

4

1 reference

11 April 2018

page(s)

1063-1065

1 reference

11 April 2018

1 reference

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

21 January 2018

1 reference

Benefits and risks of interferon therapy for hepatitis B.

21 January 2018

1 reference

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b

21 January 2018

1 reference

A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B

21 January 2018

1 reference

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

21 January 2018

1 reference

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis

21 January 2018

1 reference

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.22932

1 reference

11 April 2018

1 reference

11 April 2018